click
titles for full stories.
1 | 2 | 3
| 4 | 5
| 6 |
Headline Index
Same
PSA Levels in Older Men May Mask Worse Disease
In a study of prostate cancer at different ages, Johns Hopkins researchers
have found that at diagnosis, older men have more extensive disease
than younger men even if their prostate specific antigen (PSA) levels
are the same. PSA is a protein made by the prostate; rising blood levels
suggest that the prostate is enlarged or even cancerous. Full
story
Assessing Risk Of Advanced Cancer After Radical Prostate Surgery, a New Formula
While prostate removal cures most men of their prostate cancer, more
than a third show a rise in their prostate specific antigen (PSA) levels
in the ten years following surgery, an early sign that cancer may be
returning. Now, in the largest and longest study of its kind, urologists
at Johns Hopkins have developed a method for assessing the risk these
men have for developing metastatic cancer. Full
story
"Salvage"
Cryo Survival Benefit and After-Effects Uncertain
June 22, 1999Cryosurgery for men with prostate cancer who undergo
the procedure because radiation therapy was not effective requires more
research to determine the long-term outcomes, says a new technology
assessment by the US Medicare agency, AHCPR Full
story
Taxotere,
Emyct and Hydrocortisone "Effective" For Advanced Prostate
Cancer
May 16, 1999 Chemotherapy using docetaxel, estramustine and low-dose hydrocortisone
showed "impressive results" for hormone refractory prostate
cancer in a Phase II NIC-sponsored study, according to a paper presented
at the annual meeting of the American Society of Clinical Oncology (ASCO).
Full
story
|